Journal of Pharmaceutical and Biomedical Sciences

Novel Vesicular Carrier for Enhanced Transdermal Delivery of Tramadol Hydrochloride Transfersomal Gel

Shastrulagari S. Shivani, Kumar M Srujan

Abstract


The main aim of current probe is to formulate and evaluate transfersomal gel for effective transdermal delivery of Tramadol Hcl. It was investigated by encapsulating the drug in various formulations which composed of various ratios of phosphatidyl choline, propylene glycol and ethanol prepared by lipid film hydration by conventional rotary evaporation method. The shapes of most Tramadol Hcl-containing Transfersomes were found to be spherical from SEM analysis. The percentage entrapment efficiency of optimised formulation T5 were found to be 92.71±0.56. The prepared formulations had been characterised for the loaded drug amount and vesicle size. The prepared vesicular systems were incorporated into 1% carbopol 934 gel. In vitro skin permeation studies were carried out by cellophane membrane using a Franz diffusion cell. Transfersome gel was found to increase the skin permeation and deposition showing a controlled effect.

Keywords


Tramadol hydrochloride, Transfersomes, transdermal delivery, entrapment efficiency, in vitro drug permeation studies

Full Text:

References


Shaw JE, Chandrasekaran SK. In: Greaves MW, Shuster S (eds): Pharmacology of the Skin. Berlin: Springer-Verlag; 1999. pp.115–22.

Modi CD, Bharadia PD. Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res. 2012;2(3):71–91.

Swarnlata S, Gunjan J, Chanchal DK, Shailendra S. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for anti-wrinkle effect. African J Pharm Pharmacol. 2011;5(8):1054–62.

Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophy Acta. 1998;1368:201–15.

Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3(6):727–37.

Patel R, Singh SK, Singh S, Sheth NR, Gendle R. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res. 2009;1(4):71–81.

Cevc G, Blume G, Schätzlein A, Gebauer D, Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Advance Drug Delivery Reviews. 1996; 18: 349–78.

Prajapati ST, Patel CG, Patel CN. Transfersomes: a vesicular carrier system for transdermal drug delivery. Asian J Biochem Pharmaceut Res. 2011;1(2):507–24.

Vinod KR, Kumar MS, Anbazhagan S, Sandhya S, Saikumar P, Rohit RT, et al. Critical issues related to transfersomes—novel vesicular system. Acta Sci Pol Technol Aliment. 2012;11(1):67–82.

Planas ME, Gonzalez P, Rodriguez S, Sanchez G, Cevc G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg.1992;75(4): 615–21.

Ramesh P. Transdermal delivery of drugs. Indian J Pharmacol. 1997;29:140–56.

Paul A, Cevec G, Bachhavat BK. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur J Immunol. 1995;25:3521–4.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.